Bivalirudin Started during Emergency Transport for Primary PCI
Why the study?
Does bivalirudin started during transport improve 30-day clinical outcomes in patients undergoing primary PCI?
Population
Patients undergoing emergency transport for primary PCI
Design
Other
Follow-up
30-day
Authors
Discussion
Loading...
Member takes
Implication
May support prehospital bivalirudin in primary PCI for lower bleeding; leaves open mitigation of acute stent thrombosis.
Key Points
- The central aim was to evaluate the impact of bivalirudin started during emergency transport on 30-day clinical outcomes.
- Randomized trial design, examining bivalirudin initiation during transport for primary PCI.
- Evaluation of major bleeding and acute stent thrombosis as key outcomes.
- Improved 30-day clinical outcomes with bivalirudin initiation.
- Reduction in major bleeding incidents.
- Increase in acute stent thrombosis rates.
Structured PICO
Does bivalirudin started during transport improve 30-day clinical outcomes in patients undergoing primary PCI?
P
Population
Patients undergoing emergency transport for primary PCI
I
Intervention
Bivalirudin started during transport
O
Outcome
30-day clinical outcomes
Pre-hospital administration of bivalirudin for primary PCI improves 30-day outcomes and reduces bleeding, but increases the risk of acute stent thrombosis.
Cite This Study
Steg et al. (2013) studied this question.